Enzyme ALPK2: A therapeutic target for a lethal form of heart failure
Researchers from the Nagoya University Graduate School of Medicine identified an enzyme, alpha-kinase 2 (ALPK2) that is ...
Johns Hopkins Medicine16h
Computer Model Helps ID Cancer-Fighting Immune Cells Key to Immunotherapy
Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...
News Medical on MSN4h
ALPK2 identified as promising new therapeutic target for treatment of heart failure
Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically ...